GBLX — GB Sciences Balance Sheet
0.000.00%
- $3.31m
- $4.80m
Annual balance sheet for GB Sciences, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 0.228 | 0.152 | 0.793 | 0.234 | 0.11 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.488 | 5.34 | — | — | — |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 3.47 | 7 | 3.54 | 0.328 | 0.309 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 23.5 | 5.56 | 0.025 | 0 | — |
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 30 | 14.4 | 10.8 | 2.55 | 0.352 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 6.71 | 10.9 | 8.6 | 3.94 | 4.76 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 21.7 | 14.4 | 12.3 | 4.33 | 4.76 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 8.3 | -0.088 | -1.47 | -1.78 | -4.41 |
Total Liabilities & Shareholders' Equity | 30 | 14.4 | 10.8 | 2.55 | 0.352 |
Total Common Shares Outstanding |